EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Longitudinal associations of chemotherapy-induced peripheral neuropathy with psychological distress and health-related quality of life in colorectal cancer survivors: a prospective cohort study

Längsschnittliche Zusammenhänge von chemotherapieinduzierter peripherer Neuropathie mit psychischer Belastung und gesundheitsbezogener Lebensqualität bei Darmkrebsüberlebenden: prospektive Kohortenstudie

N D Boekhoudt, F Mols, C Simons, N R Querido, S O Breukink, L Valkenburg-van Iersel, M L G Janssen-Heijnen, E T P Keulen, M P Weijenberg, M J L Bours

Journal of Cancer Survivorship · 2026-10 · 20 (5) · 2339-2349

DOI: 10.1007/s11764-025-01906-1 ↗

Auf einen Blick

Bei 124 mit Oxaliplatin behandelten CRC-Überlebenden waren stärkere CIPN-Symptome mit mehr psychischer Belastung und schlechterer HRQoL bis 5 Jahre nach Therapie verbunden.

Fragestellung

Welchen Zusammenhang haben CIPN-Symptome mit psychischer Belastung und HRQoL bei oxaliplatinbehandelten CRC-Überlebenden bis 5 Jahre nach Therapie?

Methode

Prospektive Kohortenstudie mit longitudinalen Analysen; CIPN, HADS und EORTC QLQ-C30 wurden wiederholt bis 60 Monate erhoben; Analyse mit linear gemischten Regressionsmodellen.

Ergebnisse

124 Patient:innen. CIPN-Symptome waren 6 Wochen nach Therapie am höchsten und nahmen danach ab. Stärkere CIPN war longitudinal mit mehr Angst, Depressivität, schlechterem globalen Gesundheits-/QoL-Status, schlechterer körperlicher und sozialer Funktion sowie mehr Fatigue assoziiert.

Schlussfolgerung der Autor:innen

CIPN-Symptome, die bei oxaliplatinbehandelten CRC-Überlebenden über die Zeit persistierten, waren bis 5 Jahre nach der Chemotherapie longitudinal mit mehr psychischer Belastung und niedrigerer HRQoL verbunden.

Kernaussagen

  • Stärkere CIPN war mit mehr Angst- und Depressionssymptomen assoziiert.
  • Auch globale Gesundheit/QoL sowie körperliche und soziale Funktion waren schlechter.
  • Die CIPN-Symptome waren 6 Wochen nach Therapie am höchsten.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Cancer Survivorship, online erschienen am 21.11.2025. Verfasst von N D Boekhoudt und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Quality of Life, Peripheral Nervous System Diseases, Cancer Survivors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Cancer Research Fund International, KWF Kankerbestrijding, Kankeronderzoekfonds Limburg, The Netherlands.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Colorectal cancer (CRC) survivors receiving oxaliplatin-based chemotherapy frequently develop chemotherapy-induced peripheral neuropathy (CIPN). This study investigated the impact of CIPN symptoms on psychological distress and health-related quality of life (HRQoL) among oxaliplatin-treated CRC survivors up to 5 years post-treatment.

Methods

124 CRC patients treated with oxaliplatin-based chemotherapy participating in a prospective cohort study were included in the longitudinal analyses. CIPN symptoms were measured at diagnosis (pre-treatment) and at 6 weeks and 6, 12, 24, and 60 months post-treatment using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-CIPN20 (EORTC QLQ-CIPN20). Psychological distress, including anxiety and depressive symptoms, and HRQoL were measured at all post-treatment time points using the Hospital Anxiety and Depression Scale (HADS) and the EORTC QLQ-Core 30 (EORTC QLQ-C30), respectively. Confounder-adjusted longitudinal associations of CIPN symptoms with psychological distress and HRQoL were analysed with linear mixed regression models.

Results

CIPN symptoms in oxaliplatin-treated CRC patients were highest at 6 weeks post-treatment, thereafter gradually decreasing over time. More severe CIPN symptoms were longitudinally associated with more psychological distress (HADS), including both higher anxiety and depressive symptoms, and with worse global health/QoL and physical and social functioning and more fatigue (EORTC QLQ-C30).

Conclusion

CIPN symptoms, persisting over time among oxaliplatin-treated CRC survivors, were longitudinally associated with more psychological distress and lower HRQoL up to 5 years after chemotherapy treatment. Implications for Cancer Survivors CIPN symptoms following oxaliplatin-based chemotherapy have a long-lasting impact on CRC survivors. Research on interventions aimed at mitigating CIPN symptoms is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsQuality of LifePeripheral Nervous System DiseasesCancer SurvivorsPsychological DistressAntineoplastic Combined Chemotherapy ProtocolsHumansMaleFemaleProspective StudiesMiddle AgedAgedOxaliplatinLongitudinal Studies

Stichwörter der Autor:innen

Cancer survivorsChemotherapy-induced peripheral neuropathyColorectal cancerHealth-related quality of lifePsychological distress

Substanzen

Oxaliplatin

Autor:innen und Institutionen

  • Department of Epidemiology, GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
  • Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands.
  • Department of Surgery, GROW Research Institute for Oncology and Reproduction, NUTRIM Institute of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, The Netherlands.
  • Department of Internal Medicine, Division of Medical Oncology, GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands.
  • Department of Clinical Epidemiology, VieCuri Medical Centre, Venlo, The Netherlands.
  • Department of Internal Medicine and Gastroenterology, Zuyderland Medical Centre Sittard-Geleen, Geleen, The Netherlands.

Förderung

  • World Cancer Research Fund International
  • KWF Kankerbestrijding
  • Kankeronderzoekfonds Limburg, The Netherlands

Zitieren

APA

Boekhoudt, N. D., Mols, F., Simons, C., Querido, N. R., Breukink, S. O., Valkenburg-van Iersel, L., Janssen-Heijnen, M. L. G., Keulen, E. T. P., Weijenberg, M. P., & Bours, M. J. L. (2026). Longitudinal associations of chemotherapy-induced peripheral neuropathy with psychological distress and health-related quality of life in colorectal cancer survivors: a prospective cohort study. Journal of Cancer Survivorship, 20(5), 2339-2349. https://doi.org/10.1007/s11764-025-01906-1

Vancouver

Boekhoudt ND, Mols F, Simons C, Querido NR, Breukink SO, Valkenburg-van Iersel L, et al. Longitudinal associations of chemotherapy-induced peripheral neuropathy with psychological distress and health-related quality of life in colorectal cancer survivors: a prospective cohort study. Journal of Cancer Survivorship. 2026;20(5):2339-2349. doi:10.1007/s11764-025-01906-1

BibTeX
@article{Boekhoudt2026,
  author = {Boekhoudt, N D and Mols, F and Simons, C and Querido, N R and Breukink, S O and Valkenburg-van Iersel, L and Janssen-Heijnen, M L G and Keulen, E T P and Weijenberg, M P and Bours, M J L},
  title = {Longitudinal associations of chemotherapy-induced peripheral neuropathy with psychological distress and health-related quality of life in colorectal cancer survivors: a prospective cohort study},
  journal = {Journal of Cancer Survivorship},
  year = {2026},
  volume = {20},
  number = {5},
  pages = {2339--2349},
  doi = {10.1007/s11764-025-01906-1}
}
Kostenlos starten →